Pediatrix Medical Group, Inc. (MD) DCF Valuation

Pediatrix Medical Group, Inc. (MD) DCF Valuation

US | Healthcare | Medical - Care Facilities | NYSE
Pediatrix Medical Group, Inc. (MD) DCF Valuation

Fully Editable: Tailor To Your Needs In Excel Or Sheets

Professional Design: Trusted, Industry-Standard Templates

Investor-Approved Valuation Models

MAC/PC Compatible, Fully Unlocked

No Expertise Is Needed; Easy To Follow

Pediatrix Medical Group, Inc. (MD) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you’re an investor or an analyst, this (MD) DCF Calculator is your go-to resource for accurate valuation. Preloaded with real data from Pediatrix Medical Group, Inc., you can adjust forecasts and immediately observe the results.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2020		 AY2
2021		 AY3
2022		 AY4
2023		 AY5
2024		 FY1
2025		 FY2
2026		 FY3
2027		 FY4
2028		 FY5
2029
Revenue 1,734.0 1,911.2 1,972.0 1,994.6 2,012.9 2,090.8 2,171.6 2,255.6 2,342.8 2,433.4
Revenue Growth, % 0 10.22 3.18 1.15 0.91641 3.87 3.87 3.87 3.87 3.87
EBITDA 200.4 249.9 235.6 29.9 -28.4 153.3 159.3 165.4 171.8 178.5
EBITDA, % 11.56 13.07 11.95 1.5 -1.41 7.33 7.33 7.33 7.33 7.33
Depreciation 28.4 32.1 35.6 36.2 32.2 35.7 37.1 38.5 40.0 41.6
Depreciation, % 1.64 1.68 1.81 1.81 1.6 1.71 1.71 1.71 1.71 1.71
EBIT 171.9 217.7 200.0 -6.3 -60.6 117.6 122.2 126.9 131.8 136.9
EBIT, % 9.92 11.39 10.14 -0.31504 -3.01 5.62 5.62 5.62 5.62 5.62
Total Cash 1,228.7 387.4 9.8 177.7 348.5 492.8 511.9 531.7 552.2 573.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 241.9 301.8 296.8 279.9 272.6
Account Receivables, % 13.95 15.79 15.05 14.03 13.54
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0.0000000577 0.0000000523 0.0000000507 0 0 0.0000000321 0.0000000321 0.0000000321 0.0000000321 0.0000000321
Accounts Payable 59.8 36.6 31.9 34.6 46.4 46.1 47.9 49.7 51.6 53.6
Accounts Payable, % 3.45 1.92 1.62 1.73 2.31 2.2 2.2 2.2 2.2 2.2
Capital Expenditure -28.8 -32.2 -29.7 -33.3 -22.0 -31.9 -33.1 -34.4 -35.7 -37.1
Capital Expenditure, % -1.66 -1.69 -1.51 -1.67 -1.09 -1.52 -1.52 -1.52 -1.52 -1.52
Tax Rate, % -2.24 -2.24 -2.24 -2.24 -2.24 -2.24 -2.24 -2.24 -2.24 -2.24
EBITAT -230.4 210.9 163.0 -7.8 -62.0 89.0 92.4 96.0 99.7 103.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -412.9 127.8 169.2 14.6 -32.6 62.5 86.5 89.9 93.4 97.0
WACC, % 6.6 8.79 8.44 8.86 8.86 8.31 8.31 8.31 8.31 8.31
PV UFCF
SUM PV UFCF 335.1
Long Term Growth Rate, % 3.50
Free cash flow (T + 1) 100
Terminal Value 2,087
Present Terminal Value 1,400
Enterprise Value 1,735
Net Debt 432
Equity Value 1,303
Diluted Shares Outstanding, MM 86
Equity Value Per Share 15.17

What You Will Get

  • Comprehensive MD Financials: Access historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Intrinsic value and NPV are computed automatically.
  • Scenario Analysis: Evaluate various scenarios to assess Pediatrix Medical Group’s future performance.
  • User-Friendly Design: Designed for professionals but easy for newcomers to navigate.

Key Features

  • Comprehensive MD Data: Pre-filled with Pediatrix Medical Group's historical performance metrics and future growth projections.
  • Fully Customizable Inputs: Modify revenue growth rates, profit margins, discount rates, tax implications, and capital investments.
  • Dynamic Valuation Model: Real-time updates to Net Present Value (NPV) and intrinsic value based on your customized inputs.
  • Scenario Testing: Generate various forecasting scenarios to explore different valuation results.
  • User-Friendly Design: Intuitive layout, structured for both industry professionals and newcomers.

How It Works

  • Step 1: Download the prebuilt Excel template containing Pediatrix Medical Group, Inc.'s (MD) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see recalculated results, including Pediatrix Medical Group, Inc.'s (MD) intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or generate comprehensive reports.

Why Choose This Calculator?

  • User-Friendly Interface: Crafted for both novices and seasoned professionals.
  • Customizable Inputs: Easily adjust parameters to suit your analysis needs.
  • Real-Time Feedback: Witness immediate updates to Pediatrix Medical Group’s valuation as you modify inputs.
  • Preloaded Data: Comes with Pediatrix Medical Group’s actual financial figures for swift assessments.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed decisions.

Who Should Use This Product?

  • Investors: Evaluate Pediatrix Medical Group’s (MD) fair value to inform investment strategies.
  • CFOs: Utilize a comprehensive DCF model for accurate financial reporting and analysis.
  • Consultants: Easily customize the template for client valuation reports in the healthcare sector.
  • Entrepreneurs: Discover financial modeling techniques employed by leading healthcare organizations.
  • Educators: Employ it as a resource for teaching valuation techniques in finance courses.

What the Template Contains

  • Preloaded MD Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

No products were found matching.